Gillian Knowles1, Rachel Haigh2, Catriona McLean3, Hamish Phillips4. 1. Edinburgh Cancer Centre, Lothian University Hospitals Division, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. Electronic address: gillian.knowles@luht.scot.nhs.uk. 2. Edinburgh Cancer Centre, Lothian University Hospitals Division, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. Electronic address: rachel.haigh@luht.scot.nhs.uk. 3. Edinburgh Cancer Centre, Lothian University Hospitals Division, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. Electronic address: catriona.mclean@luht.scot.nhs.uk. 4. Edinburgh Cancer Centre, Lothian University Hospitals Division, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. Electronic address: hamish.phillips@luht.scot.nhs.uk.
Abstract
PURPOSE: The aim of this study was to evaluate the late effects and quality of life of patients following chemo-radiation treatment for anal cancer. METHODS: All surviving anal cancer patients treated within NHS Lothian between 1990 and 2007 were invited to participate. Data were collected using the EORTC QLQ-C30, the EORTC QLQ-CR38 and the Memorial Sloan-Kettering Cancer Centre Bowel Function Instrument (MSKCC). RESULTS: Overall response rate was 46% (n = 42); mean age 54.7 years and with a median time interval of 63.8 months between treatment and completion of the questionnaires. Thirty-five percent of the participants were 'rarely' or 'never' able to wait 15 min to get to the toilet; 50% were 'rarely' or 'never' able to control the passage of gas; 35% limited the types of solid foods they eat; 22% had leakage of stool during the day; 39% required to use a protective pad and 29% altered their daily activities because of bowel function 'always' or 'most of the time'. Seventeen percent of patients reported financial difficulties ('quite a bit' and 'very much'). Both men and women reported high symptomology for sexual problems with a median score of 83.3 (50.0. 100.0). CONCLUSION: This study has shown that in a sub-set of patients treated with chemo-radiation for anal cancer, persistent treatment related issues are reported at a medium time interval of 5.3 years. Further work is now required to understand the impact of symptoms on day-to-day life and the challenges that people face in managing these inter-related and complex problems.
PURPOSE: The aim of this study was to evaluate the late effects and quality of life of patients following chemo-radiation treatment for anal cancer. METHODS: All surviving anal cancerpatients treated within NHS Lothian between 1990 and 2007 were invited to participate. Data were collected using the EORTC QLQ-C30, the EORTC QLQ-CR38 and the Memorial Sloan-Kettering Cancer Centre Bowel Function Instrument (MSKCC). RESULTS: Overall response rate was 46% (n = 42); mean age 54.7 years and with a median time interval of 63.8 months between treatment and completion of the questionnaires. Thirty-five percent of the participants were 'rarely' or 'never' able to wait 15 min to get to the toilet; 50% were 'rarely' or 'never' able to control the passage of gas; 35% limited the types of solid foods they eat; 22% had leakage of stool during the day; 39% required to use a protective pad and 29% altered their daily activities because of bowel function 'always' or 'most of the time'. Seventeen percent of patients reported financial difficulties ('quite a bit' and 'very much'). Both men and women reported high symptomology for sexual problems with a median score of 83.3 (50.0. 100.0). CONCLUSION: This study has shown that in a sub-set of patients treated with chemo-radiation for anal cancer, persistent treatment related issues are reported at a medium time interval of 5.3 years. Further work is now required to understand the impact of symptoms on day-to-day life and the challenges that people face in managing these inter-related and complex problems.
Authors: Stacy Tessler Lindau; Emily M Abramsohn; Shirley R Baron; Judith Florendo; Hope K Haefner; Anuja Jhingran; Vanessa Kennedy; Mukta K Krane; David M Kushner; Jennifer McComb; Diane F Merritt; Julie E Park; Amy Siston; Margaret Straub; Lauren Streicher Journal: CA Cancer J Clin Date: 2016-01-19 Impact factor: 508.702
Authors: Hendrik Dapper; Markus Oechsner; Stefan Münch; Christian Diehl; Jan C Peeken; Kai Borm; Stephanie E Combs Journal: Strahlenther Onkol Date: 2020-02-03 Impact factor: 3.621
Authors: Pavel Vítek; Jiří Kubeš; Vladimír Vondráček; Michal Andrlik; Matěj Navrátíl; Radek Zapletal; Alexandra Haas; Kateřina Dědečková; Barbora Ondrová; Alexander Grebenyuk; Jozef Rosina Journal: Cancers (Basel) Date: 2021-12-31 Impact factor: 6.639
Authors: Christina Sauter; Jan C Peeken; Kai Borm; Christian Diehl; Stefan Münch; Stephanie E Combs; Hendrik Dapper Journal: Sci Rep Date: 2022-03-15 Impact factor: 4.379